1. Home
  2. XERS vs INDI Comparison

XERS vs INDI Comparison

Compare XERS & INDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • INDI
  • Stock Information
  • Founded
  • XERS 2005
  • INDI 2007
  • Country
  • XERS United States
  • INDI United States
  • Employees
  • XERS N/A
  • INDI N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • INDI Semiconductors
  • Sector
  • XERS Health Care
  • INDI Technology
  • Exchange
  • XERS Nasdaq
  • INDI Nasdaq
  • Market Cap
  • XERS 752.7M
  • INDI 610.0M
  • IPO Year
  • XERS 2018
  • INDI N/A
  • Fundamental
  • Price
  • XERS $5.49
  • INDI $3.88
  • Analyst Decision
  • XERS Strong Buy
  • INDI Strong Buy
  • Analyst Count
  • XERS 6
  • INDI 6
  • Target Price
  • XERS $6.25
  • INDI $6.08
  • AVG Volume (30 Days)
  • XERS 1.8M
  • INDI 4.2M
  • Earning Date
  • XERS 08-07-2025
  • INDI 08-07-2025
  • Dividend Yield
  • XERS N/A
  • INDI N/A
  • EPS Growth
  • XERS N/A
  • INDI N/A
  • EPS
  • XERS N/A
  • INDI N/A
  • Revenue
  • XERS $222,551,000.00
  • INDI $218,406,000.00
  • Revenue This Year
  • XERS $35.31
  • INDI $7.46
  • Revenue Next Year
  • XERS $19.65
  • INDI $32.80
  • P/E Ratio
  • XERS N/A
  • INDI N/A
  • Revenue Growth
  • XERS 29.88
  • INDI N/A
  • 52 Week Low
  • XERS $2.10
  • INDI $1.53
  • 52 Week High
  • XERS $6.07
  • INDI $5.57
  • Technical
  • Relative Strength Index (RSI)
  • XERS 62.75
  • INDI 45.60
  • Support Level
  • XERS $4.94
  • INDI $3.83
  • Resistance Level
  • XERS $5.22
  • INDI $4.39
  • Average True Range (ATR)
  • XERS 0.22
  • INDI 0.35
  • MACD
  • XERS -0.01
  • INDI -0.11
  • Stochastic Oscillator
  • XERS 86.44
  • INDI 9.40

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for advanced Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.

Share on Social Networks: